What is Retractable Technologies Return-on-Tangible-Equity?
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Retractable Technologies's annualized net income for the quarter that ended in Mar. 2024 was $1.72 Mil. Retractable Technologies's average shareholder tangible equity for the quarter that ended in Mar. 2024 was $99.47 Mil. Therefore, Retractable Technologies's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was 1.73%.
The historical rank and industry rank for Retractable Technologies's Return-on-Tangible-Equity or its related term are showing as below:
RVP'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -13.52 Med: -0.07 Max: 75.23
Current: -7.43
During the past 13 years, Retractable Technologies's highest Return-on-Tangible-Equity was 75.23%. The lowest was -13.52%. And the median was -0.07%.
RVP's Return-on-Tangible-Equity is ranked worse than 58.68% of 760
companies
in the Medical Devices & Instruments industry
Industry Median: 1.32
vs RVP: -7.43
Retractable Technologies Return-on-Tangible-Equity Historical Data
The historical data trend for Retractable Technologies's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Retractable Technologies's Return-on-Tangible-Equity
For the Medical Instruments & Supplies subindustry, Retractable Technologies's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Retractable Technologies's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Retractable Technologies's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2024) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Retractable Technologies Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of Retractable Technologies's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Retractable Technologies (Retractable Technologies) Business Description
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to its other products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RVP has been successfully added to your 